SUPN · Forms 3, 4, 5

Insider trades at SUPERNUS PHARMACEUTICALS, INC.

No open-market insider buys or sells at SUPERNUS PHARMACEUTICALS, INC. in the last 90 days; 10 filings reported awards, option exercises, tax withholding or new insiders.

Every Form 3, 4 and 5 filed for SUPERNUS PHARMACEUTICALS, INC. (SUPN) with the SEC, newest first: who traded, their role, buy or sell, shares, price and value.

Insider trades in the last 90 days

DateInsiderRoleTransactionSharesPriceValueFiling
Jack A. KhattarPresident, CEOOption exercise29,849Form 4
Jack A. KhattarPresident, CEOTax withholding12,642$46.57$589KForm 4
Jonathan RubinSVP, Chief Medical OfficerOption exercise750Form 4
Jonathan RubinSVP, Chief Medical OfficerTax withholding363$46.57$17KForm 4
Padmanabh P. BhattSr. VP of IP, CSOOption exercise2,500Form 4
Padmanabh P. BhattSr. VP of IP, CSOTax withholding1,158$46.57$54KForm 4
Frank MottolaSVP, Chief Tech. Ops. OfficerOption exercise1,650Form 4
Frank MottolaSVP, Chief Tech. Ops. OfficerTax withholding797$46.57$37KForm 4
Timothy C DecSenior Vice-President & CFOOption exercise1,250Form 4
Timothy C DecSenior Vice-President & CFOTax withholding604$46.57$28KForm 4
Jack A. KhattarPresident, CEOOptions or other derivativesForm 4
Timothy C DecSenior Vice-President & CFOOptions or other derivativesForm 4
Frank MottolaSVP, Chief Tech. Ops. OfficerOptions or other derivativesForm 4
Padmanabh P. BhattSr. VP of IP, CSOOptions or other derivativesForm 4
Jonathan RubinSVP, Chief Medical OfficerOptions or other derivativesForm 4

Buy and Sell are open-market purchases and sales (transaction codes P and S), the trades investors watch. Awards, option exercises, tax withholding and gifts are reported too but are not market trades.